JP2012513403A5 - - Google Patents

Download PDF

Info

Publication number
JP2012513403A5
JP2012513403A5 JP2011542539A JP2011542539A JP2012513403A5 JP 2012513403 A5 JP2012513403 A5 JP 2012513403A5 JP 2011542539 A JP2011542539 A JP 2011542539A JP 2011542539 A JP2011542539 A JP 2011542539A JP 2012513403 A5 JP2012513403 A5 JP 2012513403A5
Authority
JP
Japan
Prior art keywords
desmopressin
patient
dispenser
target
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011542539A
Other languages
English (en)
Japanese (ja)
Other versions
JP5731396B2 (ja
JP2012513403A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/068962 external-priority patent/WO2010075266A2/en
Publication of JP2012513403A publication Critical patent/JP2012513403A/ja
Publication of JP2012513403A5 publication Critical patent/JP2012513403A5/ja
Application granted granted Critical
Publication of JP5731396B2 publication Critical patent/JP5731396B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011542539A 2008-12-22 2009-12-21 鼻腔内デスモプレシン投与 Active JP5731396B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13987108P 2008-12-22 2008-12-22
US61/139,871 2008-12-22
PCT/US2009/068962 WO2010075266A2 (en) 2008-12-22 2009-12-21 Safe desmopressin administration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015080138A Division JP5959076B2 (ja) 2008-12-22 2015-04-09 鼻腔内デスモプレシン投与

Publications (3)

Publication Number Publication Date
JP2012513403A JP2012513403A (ja) 2012-06-14
JP2012513403A5 true JP2012513403A5 (cg-RX-API-DMAC7.html) 2013-02-14
JP5731396B2 JP5731396B2 (ja) 2015-06-10

Family

ID=42168193

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2011542539A Active JP5731396B2 (ja) 2008-12-22 2009-12-21 鼻腔内デスモプレシン投与
JP2015080138A Active JP5959076B2 (ja) 2008-12-22 2015-04-09 鼻腔内デスモプレシン投与
JP2016120760A Active JP6389209B2 (ja) 2008-12-22 2016-06-17 鼻腔内デスモプレシン投与
JP2018113951A Pending JP2018184407A (ja) 2008-12-22 2018-06-14 鼻腔内デスモプレシン投与

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2015080138A Active JP5959076B2 (ja) 2008-12-22 2015-04-09 鼻腔内デスモプレシン投与
JP2016120760A Active JP6389209B2 (ja) 2008-12-22 2016-06-17 鼻腔内デスモプレシン投与
JP2018113951A Pending JP2018184407A (ja) 2008-12-22 2018-06-14 鼻腔内デスモプレシン投与

Country Status (19)

Country Link
US (4) US20120015880A1 (cg-RX-API-DMAC7.html)
EP (2) EP2381923B2 (cg-RX-API-DMAC7.html)
JP (4) JP5731396B2 (cg-RX-API-DMAC7.html)
KR (2) KR20170081711A (cg-RX-API-DMAC7.html)
CN (2) CN105963834A (cg-RX-API-DMAC7.html)
AU (1) AU2009330203B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0923557A2 (cg-RX-API-DMAC7.html)
CA (1) CA2747998C (cg-RX-API-DMAC7.html)
DK (1) DK2381923T4 (cg-RX-API-DMAC7.html)
EA (2) EA201791732A1 (cg-RX-API-DMAC7.html)
ES (1) ES2692345T5 (cg-RX-API-DMAC7.html)
IL (1) IL213699A (cg-RX-API-DMAC7.html)
MX (1) MX2011006765A (cg-RX-API-DMAC7.html)
NZ (1) NZ593613A (cg-RX-API-DMAC7.html)
PL (1) PL2381923T5 (cg-RX-API-DMAC7.html)
PT (1) PT2381923T (cg-RX-API-DMAC7.html)
SG (2) SG10201509152VA (cg-RX-API-DMAC7.html)
WO (1) WO2010075266A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201105420B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009021007A1 (en) 2007-08-06 2009-02-12 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
SG10201509152VA (en) * 2008-12-22 2015-12-30 Allergan Inc Intranasal desmopressin administration
CA2765221C (en) * 2009-06-18 2017-10-03 Allergan, Inc. Safe desmopressin administration
EP3024473A1 (en) 2013-07-23 2016-06-01 Allergan, Inc. Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor
CN105579057A (zh) * 2013-07-23 2016-05-11 阿勒根公司 包含与β-3-肾上腺素能受体激动剂组合的去氨加压素的方法和组合物
CA2967390A1 (en) 2014-11-20 2016-05-26 Allergan, Inc. Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS171787B1 (cg-RX-API-DMAC7.html) 1973-11-09 1976-11-29
US4148787A (en) 1976-05-24 1979-04-10 Ferring Ab Antidiuretically effective polypeptide and a process for preparing the same
US4771769A (en) 1982-12-20 1988-09-20 Schering Corporation Hand held metered spray dispenser
US4548922A (en) 1983-06-06 1985-10-22 Beth Israel Hospital Drug administration
US4746508A (en) 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US5731303A (en) 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5112804A (en) 1987-04-01 1992-05-12 Temple University Of The Commonwealth System Of Higher Education Pharmaceutical composition and method of intranasal administration
US4944429A (en) 1987-08-28 1990-07-31 Schering Corporation Manually-operable spray dispenser with locking mechanism
US5154122A (en) 1989-10-20 1992-10-13 Sol Goldschmidt Shipping device for suspended piece goods
CN1060980A (zh) * 1990-10-26 1992-05-13 蔡东林 多用电控自控微型喷雾器
US5314694A (en) 1990-10-29 1994-05-24 Alza Corporation Transdermal formulations, methods and devices
US5122383A (en) 1991-05-17 1992-06-16 Theratech, Inc. Sorbitan esters as skin permeation enhancers
US5227169A (en) 1991-05-17 1993-07-13 Theratech, Inc. Sorbitan esters as skin permeation enhancers
US5212199A (en) 1991-05-17 1993-05-18 Theratech, Inc. Sorbitan esters as skin permeation enhancers
IT1255895B (it) 1992-10-20 1995-11-17 Laura Chiodini Composizioni farmaceutiche contenenti una calcitonina
DK0708657T3 (da) * 1993-06-29 2001-10-15 Ferring Bv Sammensætninger til nasal administration af desmopression
WO1996040332A1 (en) * 1995-06-07 1996-12-19 O'neil, Christine Patient controlled drug delivery device
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
DE19723133A1 (de) 1997-06-03 1998-12-10 Caideil M P Teoranta Tourmakea Austragvorrichtung für Medien
US7335186B2 (en) 1998-03-13 2008-02-26 Alexander George Brian O'Neil Patient controlled drug delivery device
AU3421600A (en) 1999-02-14 2000-08-29 Ing. Erich Pfeiffer Gmbh Dispenser for flowable media
DE19938798A1 (de) 1999-08-16 2001-03-01 Pfeiffer Erich Gmbh & Co Kg Spender für Flüssigkeiten oder für zähflüssige oder versprühbare Produkte
DE19940236A1 (de) 1999-08-25 2001-03-08 Pfeiffer Erich Gmbh & Co Kg Spender mit manuell betätigbarer Ausbringeinrichtung
DE10110742A1 (de) 2001-02-28 2002-09-05 Pfeiffer Erich Gmbh & Co Kg Spender für Medien
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
PL200833B1 (pl) 2001-09-21 2009-02-27 Pfeiffer Erich Gmbh & Co Kg Dozownik z pojemnikiem aplikowanego środka oraz pompka do dozownika
US20030232078A1 (en) 2001-12-19 2003-12-18 Dong Liang C. Formulation & dosage form for the controlled delivery of therapeutic agents
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
ITMI20021684A1 (it) * 2002-07-29 2004-01-29 Therapicon Srl Composizione farmaceutica di peptide nasale
US7186692B2 (en) * 2002-12-17 2007-03-06 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
WO2005046707A1 (en) * 2003-11-10 2005-05-26 Fein Seymour H Pharmaceutical compositions including low dosages of desmopressin
JP2007513199A (ja) * 2003-12-08 2007-05-24 ベントレー ファーマスーティカルス,インコーポレイテッド インスリン治療のための薬学的組成物及び方法
WO2007022345A2 (en) * 2005-08-17 2007-02-22 Fleming And Company, Pharmaceuticals Vitamin b12 nasal spray and method of use
CN1785448A (zh) * 2005-11-11 2006-06-14 广东工业大学 医用防染式药雾吸入喷嘴
EP2035031A4 (en) * 2006-06-08 2010-02-24 Cpex Pharmaceuticals Inc INSULIN COMPOSITION
SG10201509152VA (en) * 2008-12-22 2015-12-30 Allergan Inc Intranasal desmopressin administration
CA2765221C (en) 2009-06-18 2017-10-03 Allergan, Inc. Safe desmopressin administration

Similar Documents

Publication Publication Date Title
US20250241977A1 (en) Safe desmopressin administration
JP2012530708A5 (cg-RX-API-DMAC7.html)
US20240342407A1 (en) Intranasal desmopressin administration
AU2015261630B2 (en) Intranasal desmopressin administration
HK40060414A (en) Safe desmopressin administration
HK40060414B (en) Safe desmopressin administration
HK1250642B (en) Safe desmopressin administration
HK1172544B (en) Safe desmopressin administration
HK1172544A (en) Safe desmopressin administration